Literature DB >> 8099638

Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis.

A Giaid1, R P Michel, D J Stewart, M Sheppard, B Corrin, Q Hamid.   

Abstract

The vasoconstrictor and mitogenic peptide endothelin-1 (ET-1) is believed to play a part in fibrosis and collagen production. We examined expression of ET-1 in lung tissue from 52 patients with interstitial lung fibrosis, of whom 45 had cryptogenic fibrosing alveolitis (CFA), 10 had CFA and concomitant pulmonary hypertension, and 7 had non-specific focal fibrosis. 17 normal unused donor lungs were studied as controls. Immunohistochemistry and in-situ hybridisation were done with polyclonal antisera to ET-1 and its precursor big ET-1, and complementary RNA probes for preproET-1. Normal lung tissue and that from patients with focal fibrosis expressed very little ET-1. By contrast, there was striking expression of ET-1 in lung tissue from patients with CFA. Immunostains for ET-1 and big ET-1 and expression of ET-1 mRNA were most prominent in airway epithelium and type II pneumocytes, particularly those lining areas of young granulation tissue. ET-1-like immunoreactivity and mRNA were also present in pulmonary vascular endothelial cells, particularly in specimens from patients with pulmonary hypertension. In all patients, there was a significant correlation between ET-1-like immunoreactivity and histological parameters of disease activity (r = 0.78, 95% CI 0.65-0.87, p < 0.001). These findings suggest a possible role for cell-specific expression of ET-1 in the pathogenesis of CFA and associated pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099638     DOI: 10.1016/0140-6736(93)90694-c

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  48 in total

Review 1.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Interstitial lung disease in patients with hepatopulmonary syndrome: a case series and new observations.

Authors:  S Shahangian; M Y Shino; I Barjaktarevic; I Susanto; J A Belperio; M C Fishbein; T Wang
Journal:  Lung       Date:  2014-03-30       Impact factor: 2.584

Review 3.  Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.

Authors:  Jeffrey C Horowitz; Victor J Thannickal
Journal:  Treat Respir Med       Date:  2006

4.  Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis.

Authors:  Cecilia Marmai; Rachel E Sutherland; Kevin K Kim; Gregory M Dolganov; Xiaohui Fang; Sophia S Kim; Shuwei Jiang; Jeffery A Golden; Charles W Hoopes; Michael A Matthay; Harold A Chapman; Paul J Wolters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-15       Impact factor: 5.464

5.  Localization of endothelin receptors in bleomycin-induced pulmonary fibrosis in the rat.

Authors:  Martina Wendel; Anna Petzold; Roland Koslowski; Michael Kasper; Antje Augstein; Lilla Knels; Jörg-Uwe Bleyl; Thea Koch
Journal:  Histochem Cell Biol       Date:  2004-10-05       Impact factor: 4.304

Review 6.  Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis.

Authors:  Eric S White; Michael H Lazar; Victor J Thannickal
Journal:  J Pathol       Date:  2003-11       Impact factor: 7.996

7.  Expression of vasoactive mediators during mechanical ventilation in nitrofen-induced diaphragmatic hernia in rats.

Authors:  Toko Shinkai; Hideki Shima; Valeria Solari; Prem Puri
Journal:  Pediatr Surg Int       Date:  2004-11-26       Impact factor: 1.827

8.  Endothelin-1 in idiopathic pulmonary fibrosis.

Authors:  M Uguccioni; L Pulsatelli; B Grigolo; A Facchini; L Fasano; C Cinti; M Fabbri; G Gasbarrini; R Meliconi
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

Review 9.  The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Kevin K Brown
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

10.  Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.

Authors:  Priya Kulasekaran; Casey A Scavone; David S Rogers; Douglas A Arenberg; Victor J Thannickal; Jeffrey C Horowitz
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.